A South Korean medic exposed to Ebola while working in West Africa has been flown to Germany for treatment because the patient’s anonymity would be better protected there, authorities in Berlin said Saturday.
Doctors at Berlin’s renowned Charite hospital said the medic, who had worked for an aid group treating Ebola patients in Sierra Leone, arrived in Berlin Saturday, five days after suffering an injury with a hypodermic needle.
“The person wasn’t flown to South Korea because the Korean government asked Europe step in,” said Dr. Frank Bergmann, who oversees the treatment of highly infectious patients at Charite hospital. “First of all it’s good from a transportation point of view to come here and secondly it’s better for the person’s anonymity to be treated here in Europe.”
He said the South Korean government and the medic had requested that as few details as possible be released, declining to give the person’s profession, age, gender or employer.
Ebola can be transmitted through bodily fluids and persons suspected of carrying the virus have been shunned in some countries by people fearful of infection. Experts say, however, that with proper precautions patients pose no risk to those around them.
The medic had been treating a delirious Ebola patient on Monday when the patient jolted, causing the needle on a blood-filled syringe to pierce the three plastic gloves the medic was wearing, said Bergmann.
“The patient had a very high viral load and died the next day, which means that there was a very high risk of infection,” he said.
Bergmann said the medic currently shows no symptoms of Ebola, but the incubation period will last a further 16 days, during which the person will remain under close medical supervision.
Should symptoms develop, doctors could provide experimental drugs and “with our European standards there should be a good prognosis,” he added.
Source: Associated Press
Date: January 5, 2015
SUBSCRIBE TO OUR BLOG IN THE RIGHT SIDEBAR MENU TO RECEIVE OUR DAILY BLOG POST DIRECTLY TO YOUR E-MAIL
SUBSCRIBE TO OUR NEWSLETTER TO RECEIVE A MONTHLY MAIL WITH MORE RELEVANT INDUSTRY AND COMPANY NEWS